Salute e Benessere

Press Release: Availability of the Q2 2024 Aide-mémoire

Availability of the Q2 2024 Aide-mémoireParis, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2024 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity...
Nasdaq GlobeNewswire
25/06/2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from June 17th to 21th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1117/06/2024FR00102591506 600120,3723XPARIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
25/06/2024

Higher cantonal composition authority approved the amendments to the terms of…

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2024Idorsia Ltd (SIX: IDIA) today announced that the hearing by the higher cantonal composition authority ( obere kantonale Nachlassbehörde ) (the Court) in relation to its outstanding convertible bonds originally maturing on July 17, 2024 (ISIN: CH0426820350) (the Bonds), was held today and that the Court approved the amendments of the Bond terms decided at the bondholder meeting held on May 6, 2024.Idorsia...
Nasdaq GlobeNewswire
25/06/2024

New publication shows effectiveness data for weekly and monthly buprenorphine…

Of 428 trial participants, 123 (SC-BPN, n=64; SL-BPN/NX, n=59) had evidence of baseline fentanyl use. In the fentanyl-positive subgroup, the mean percentage of urine samples negative for fentanyl during the study was 74% for the SC-BPN arm versus 61.9% for the SL BPN/NX arm). Withdrawal symptoms and cravings decreased following treatment initiation in patients positive for fentanyl use at baseline. No substantial difference was observed in rates of study completion between fentanyl-positive and…
PR Newswire
25/06/2024

Neurolief Announces Breakthrough Results from Pivotal Clinical Trial of Brain…

The double-blind, randomized, placebo-controlled, multi-center clinical trial enrolled 124 participants across leading medical centers in the United States and Israel. The study's primary endpoint was a reduction in depression severity as measured by the Hamilton Depression Rating Scale (HDRS17). Key findings from the trial include: The double-blind, randomized, placebo-controlled, multi-center clinical trial enrolled 124 participants across leading medical centers inthe United…
PR Newswire
25/06/2024

Zealand Pharma launches equity offering of new shares raising gross proceeds of…

Company announcement – No. 33 / 2024Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billionNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE UNITED STATES AND THE SECURITIES...
Nasdaq GlobeNewswire
25/06/2024

Defibrillator Market to be Worth $22.76 Billion by 2031 - Exclusive Report by…

Cardioverter defibrillators are devices that detect and control heartbeats, also known as arrhythmia, and deliver electric shocks to restore a regular heart rhythm. Cardioverter defibrillators are devices that detect and control heartbeats, also known as arrhythmia, and deliver electric shocks to restore a regular heart rhythm. The growth of the defibrillator market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity, sedentary...
PR Newswire
25/06/2024

Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 -…

Research antibodies are crucial for research in several fields, including oncology, infectious diseases, cardiology, immunology, neurology, and stem cell research. Antibodies help in protein identification and detection, which can be associated with specific diseases. Furthermore, antibodies are also used in the identification of novel biomarkers which help in disease diagnosis. Research antibodies are crucial for research in several fields, including oncology, infectious diseases…
PR Newswire
25/06/2024

UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund…

"We are thrilled to lead this record round for UroMems," said Jérôme Feraud, Head of Health Division at Crédit Mutuel Innovation. "Based on very positive data and feedback from patients and physicians in the pilot clinical trials, we strongly believe that the UroActive smart implant has the potential to become the standard of care as the next-generation SUI treatment." "We are thrilled to lead this record round for UroMems," said Jérôme Feraud, Head of Health…
PR Newswire
25/06/2024

Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools…

"Metabolon has a rich history of pioneering advancements in metabolomics. We are dedicated to empowering pharmaceutical and biotechnology companies, as well as academic and government institutions, with comprehensive metabolic insights to drive better health outcomes," said Ro Hastie, CEO of Metabolon. "With this NIH grant, Metabolon is poised to extend its expertise in T1D, aiming to enhance predictive capabilities and improve the lives of millions affected by this…
PR Newswire
25/06/2024

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the…

According to the GLOBOCAN 2020 statistics, breast cancer became the most common cancer in the world, with 2.31 million new cases and 0.67 million deaths. In China, there were 0.36 million new cases and 0.07 million deaths due to breast cancer, accounting for 15.5% and 11.2% of global cases. Amongst these, TNBC accounts for about 10% to 15% of all breast cancer cases, making TNBC a more aggressive type of cancer with a higher risk of recurrence and poor prognosis. Advanced TNBC is not...
Nasdaq GlobeNewswire
25/06/2024

SKAN, the Wellcome Sanger Institute and University of Newcastle to study early…

Researchers will work with leading LCH treating research centres worldwide to cover LCH driven by different genetic mutations with SKAN specifically creating a large cohort of Indian children for the study. The study comes at a time when researchers are still grappling with understanding how some genetic mutations that drive LCH result in lesions appearing in different parts of the body at different times. Researchers hope that the study will pave the way for better understanding the disease's…
PR Newswire
25/06/2024

ELFBAR earns multiple prestigious design awards worldwide

In 2024, ELFBAR celebrated its fifth anniversary with distinction, earning gold awards for its overall concept in communication design from both the American Good Design and the French Design Award. In 2024, ELFBAR celebrated its fifth anniversary with distinction, earning gold awards for its overall concept in communication design from both theAmerican Good Designand theFrench Design Award. The awards were given in response to a special souvenir bundle for the anniversary celebration...
PR Newswire
25/06/2024

Roborock Introduces Roborock Qrevo S: Robust Robotic Performance Meets…

The Roborock Qrevo S revolutionizes home cleaning with its fully automated, multifunctional dock. This advanced dock manages routine tasks efficiently, allowing you to focus on the more important aspects of life. It features a three-stage mop washing process - slow pre-wash, medium rinse, and high-speed spin drying, similar to that of a washing machine. The dock dynamically adjusts speed and water flow, ensuring high efficiency and convenience with minimal effort. The Roborock Qrevo S...
PR Newswire
25/06/2024

AMSilk to showcase its biofabricated yarns at Europe's largest trade show…

As the only Company to have succeeded in producing continuous filament yarns from spider silk proteins, AMSilk is now ready for commercialisation and the fair provides an important opportunity to showcase how the Company is redefining the boundaries of bio-based materials. As the only Company to have succeeded in producing continuous filament yarns from spider silk proteins, AMSilk is now ready for commercialisation and the fair provides an important opportunity to showcase how the Company is...
PR Newswire
25/06/2024

Insider Information: Nexstim Plc's offering for an EUR 750,000 convertible bond…

Company Announcement, Helsinki, 25 June 2024 at 9:30 AM (EEST) Insider Information: Nexstim Plc's offering for an EUR 750,000 convertible bond has closed and EUR 650,000 of the bond was subscribed for NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nexstim Plc (NXTMH:HEX)...
Nasdaq GlobeNewswire
25/06/2024

Insider Information: Nexstim Plc launches an unsecured convertible bond offering…

Company Announcement, Helsinki, 25 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nexstim Plc (NXTMH:HEX) (“ Nexstim ” or the “ Company ”) announces...
Nasdaq GlobeNewswire
25/06/2024

NX Group Signs Strategic Partnership Agreement with Controlant of Iceland

Controlant's logo: https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050 Controlant's logo:https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050 NX's logo:https://kyodonewsprwire.jp/img/202406202471-O3-jlufE0EU Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202406202471/_prw_PI2fl_jHGSHe9r.png Headquartered inIceland, Controlant, a leading provider of real-time monitoring solutions for tracking temperature and location information during transport,...
PR Newswire
25/06/2024

Roche's OCREVUS subcutaneous administration approved by European Commission, as…

OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV) OCREVUS SC provides an additional treatment option without the need for IV facilities, expanding accessibility for patientsRoche is working closely with national health systems in Europe to ensure people with multiple sclerosis can access OCREVUS SC as quickly as possible Basel, 25 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY)...
Nasdaq GlobeNewswire
25/06/2024

RECOMMENDED CASH OFFER for MARIADB PLC by MERIDIAN BIDCO LLC which is an…

MANHATTAN BEACH, Calif., June 25, 2024 /PRNewswire/ -- On 24 May 2024, Meridian Bidco LLC ("Bidco") made an offer to acquire the entire issued and to be issued share capital of MariaDB plc ("MariaDB") (the "Offer") with the terms and conditions of the Offer set out in the offer document despatched and filed by Bidco as Exhibit (a)(1)(A) to the Tender Offer Statement and Rule 13e-3 Transaction Statement filed on Schedule TO with the US Securities and Exchange…
PR Newswire
25/06/2024

Psoriasis Market to Register Incremental Growth by 2034, Predicts DelveInsight |…

Key Takeaways from the Psoriasis Market Report Key Takeaways from the Psoriasis Market Report Discover which therapies are expected to grab major psoriasis market share @Psoriasis Market Report Psoriasis Overview Psoriasis is a chronic autoimmune skin condition characterized by the rapid growth of skin cells, leading to the formation of thick, red, scaly patches that can be itchy and sometimes painful. These patches, often referred to as plaques, commonly appear on the...
PR Newswire
24/06/2024

NABR Commends the IUCN's Decision to Reassess the Status of Long-Tailed Macaques

"NABR is pleased that the IUCN will reassess its designation of long-tailed macaques as 'Endangered'," said Matthew R. Bailey, president of NABR. "The IUCN's decision to uplist long tailed macaques to 'Endangered' in 2022 was not justified, nor supported by scientific information. NABR looks forward to working with the IUCN to ensure the scientific integrity of its processes." "NABR is pleased that the IUCN will reassess its designation of long-tailed macaques as…
PR Newswire
24/06/2024

Ultimovacs ASA announces revised terms of the employee share option program

Oslo, June 24, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, announces revised terms of the employee share option program. Ultimovacs has during the second quarter of this year implemented a cash preservation program that includes downsizing of the organization. As a measure to stimulate retention of non-redundant team members, the board of directors of Ultimovacs ASA has decided to revise the terms of...
Nasdaq GlobeNewswire
24/06/2024

Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing…

In 2024, Novo Nordisk plans to boost its current investments, aiming to allocate USD 6.8 billion towards production, a significant increase from the previous year's investment of USD 3.9 billion*.Bagsværd, Denmark, 24 June 2024– Novo Nordisk today announced plans to invest 4.1 billion US dollars (approx 27 billion Danish kroner) to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable...
Nasdaq GlobeNewswire
24/06/2024
Altri  Comunicati